| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 381.34B | 338.30B | 310.63B | 291.69B | 270.33B |
| Gross Profit | 101.80B | 81.26B | 71.60B | 65.81B | 60.32B |
| EBITDA | 57.63B | 52.77B | 47.26B | 45.66B | 41.95B |
| Net Income | 30.83B | 27.05B | 24.24B | 22.00B | 20.52B |
Balance Sheet | |||||
| Total Assets | 417.58B | 431.33B | 374.64B | 319.91B | 325.76B |
| Cash, Cash Equivalents and Short-Term Investments | 108.80B | 192.93B | 103.97B | 101.32B | 95.71B |
| Total Debt | 25.15B | 29.27B | 34.79B | 25.03B | 31.52B |
| Total Liabilities | 128.77B | 161.52B | 129.85B | 112.11B | 121.19B |
| Stockholders Equity | 279.20B | 261.17B | 236.83B | 200.52B | 197.83B |
Cash Flow | |||||
| Free Cash Flow | -8.77B | 33.69B | 23.03B | 21.63B | 33.07B |
| Operating Cash Flow | -3.41B | 37.21B | 26.15B | 26.03B | 38.41B |
| Investing Cash Flow | -59.38B | 70.25B | -8.57B | -5.63B | -8.54B |
| Financing Cash Flow | -21.62B | -18.80B | -15.08B | -14.94B | -12.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥157.28B | 14.81 | ― | 2.30% | 15.87% | 40.46% | |
67 Neutral | ¥426.31B | 18.98 | ― | 2.17% | 10.51% | 31.60% | |
66 Neutral | ¥166.90B | 15.99 | 18.89% | 2.78% | 9.16% | 59.49% | |
65 Neutral | ¥30.59B | 10.75 | 10.34% | 4.82% | -2.83% | 5.48% | |
64 Neutral | ¥809.10B | 20.55 | ― | 1.39% | 5.45% | 7.26% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥673.42B | 22.20 | 10.07% | 1.76% | 12.72% | 13.98% |